Regeneron Pharmaceuticals · Capital Lease Obligations

Latest reported$720.00Mperiod endingDec 31, 2025

REGN FY Capital Lease Obligations ($0.00 → $720.00M)

Annual capital lease obligations

High-resolution chart · PNG

REGN capital lease obligations history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Capital Lease Obligations — Annual fiscal periods (USD)
Period ending	Capital Lease Obligations (USD)
Dec 31, 2025	720,000,000
Dec 31, 2024	720,000,000
Dec 31, 2023	720,000,000
Dec 31, 2022	720,000,000
Dec 31, 2021	719,700,000
Dec 31, 2020	717,200,000
Dec 31, 2019	713,900,000
Dec 31, 2018	708,500,000
Dec 31, 2017	703,500,000
Dec 31, 2016	481,126,000
Dec 31, 2015	362,919,000
Dec 31, 2014	310,938,000
Dec 31, 2013	185,197,000
Dec 31, 2012	160,810,000
Dec 31, 2011	160,514,000
Dec 31, 2010	162,859,000
Dec 31, 2009	109,022,000
Dec 31, 2008	0
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	150,000
Dec 31, 2000	603,000
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	0
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	0
Dec 31, 1990	0